Medical Ikkou Group Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: JP3921040006
JPY
2,947.00
4 (0.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 22.97

 
2

Negative results in May 25

3

With ROCE of 9.84%, it has a very attractive valuation with a 0.72 Enterprise value to Capital Employed

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

JPY 11,306 Million (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

8.14%

stock-summary
Price to Book

0.76

Revenue and Profits:
Net Sales:
13,933 Million
(Quarterly Results - Nov 2025)
Net Profit:
291 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.25%
0%
11.25%
6 Months
-7.33%
0%
-7.33%
1 Year
36.82%
0%
36.82%
2 Years
31.56%
0%
31.56%
3 Years
16.85%
0%
16.85%
4 Years
14.67%
0%
14.67%
5 Years
-58.78%
0%
-58.78%

Medical Ikkou Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.60%
EBIT Growth (5y)
7.03%
EBIT to Interest (avg)
23.28
Debt to EBITDA (avg)
1.37
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.90
Tax Ratio
38.54%
Dividend Payout Ratio
21.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.76%
ROE (avg)
8.04%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.66
EV to EBIT
7.33
EV to EBITDA
5.05
EV to Capital Employed
0.72
EV to Sales
0.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.84%
ROE (Latest)
8.18%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 3.12% vs 0.66% in Aug 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 22.49% vs -47.69% in Aug 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,933.20",
          "val2": "13,512.00",
          "chgp": "3.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "703.70",
          "val2": "515.60",
          "chgp": "36.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.90",
          "val2": "24.40",
          "chgp": "14.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.90",
          "val2": "-84.60",
          "chgp": "95.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "290.80",
          "val2": "237.40",
          "chgp": "22.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.80%",
          "val2": "22.90%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 21.28% vs 17.71% in Feb 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is 6.06% vs 39.87% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48,393.50",
          "val2": "39,901.00",
          "chgp": "21.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,455.40",
          "val2": "2,343.10",
          "chgp": "4.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "63.80",
          "val2": "54.00",
          "chgp": "18.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-107.50",
          "val2": "-254.00",
          "chgp": "57.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,147.10",
          "val2": "1,081.60",
          "chgp": "6.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.00%",
          "val2": "39.10%",
          "chgp": "-0.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQstock-summary

Nov'25
Aug'25
Change(%)
Net Sales
13,933.20
13,512.00
3.12%
Operating Profit (PBDIT) excl Other Income
703.70
515.60
36.48%
Interest
27.90
24.40
14.34%
Exceptional Items
-3.90
-84.60
95.39%
Consolidate Net Profit
290.80
237.40
22.49%
Operating Profit Margin (Excl OI)
34.80%
22.90%
1.19%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Nov 2025 is 3.12% vs 0.66% in Aug 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is 22.49% vs -47.69% in Aug 2025

Annual Results Snapshot (Consolidated) - Feb'25stock-summary

Feb'25
Feb'24
Change(%)
Net Sales
48,393.50
39,901.00
21.28%
Operating Profit (PBDIT) excl Other Income
2,455.40
2,343.10
4.79%
Interest
63.80
54.00
18.15%
Exceptional Items
-107.50
-254.00
57.68%
Consolidate Net Profit
1,147.10
1,081.60
6.06%
Operating Profit Margin (Excl OI)
35.00%
39.10%
-0.41%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2025 is 21.28% vs 17.71% in Feb 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2025 is 6.06% vs 39.87% in Feb 2024

stock-summaryCompany CV
About Medical Ikkou Group Co., Ltd. stock-summary
stock-summary
Medical Ikkou Group Co., Ltd.
Retailing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available